Trials

Rituximab plus lenalidomide or rituximab monotherapy for untreated patients with follicular lymphoma in need of therapy. A randomized, open-label, multicentre phase II trial

Cancer type: Lymphoma

Phase: II

Principal Investigator: Hernberg Micaela

Country: FI

Keywords: Lymphoma, Finland, Norway

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01307605?term=SAKK&rank=5